Xu, Xiao
Kwiatek, Justin
Siddall, James
Genofre, Eduardo
Stirnadel-Farrant, Heide
Katial, Rohit
Funding for this research was provided by:
AstraZeneca
Article History
Received: 25 October 2023
Accepted: 22 July 2024
First Online: 3 August 2024
Declarations
:
: The study was conducted according to standard operating procedures. Research was conducted as a survey in accordance with the amended Declaration of Helsinki, adhering to the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics, the international code on observational research, and HIPAA (Health Insurance Portability and Accountability Act of 1996) guidelines. The survey was submitted to a central international review board (Western Institutional Review Board) and found to be exempt from ethics requirements on 23 July 2020 (Study Number: 1-1328144-1).
: Not applicable.
: Yes - X.X., J.K., R.K., E.G., and H.S.-F. are or were employees of AstraZeneca at the time of this study and may own stock. J.S. is an employee of Adelphi Real World, which received funding from AstraZeneca to conduct this analysis.